Madhya Pradesh Doctor Who Prescribed Deadly Cough Syrup To Children Arrested

The Madhya Pradesh government also filed a case against Srisan Pharmaceuticals, the company that manufactured the Coldrif syrup.

Bhopal: The doctor in Madhya Pradesh’s Chhindwara who prescribed Coldrif syrup to children has been arrested amid a massive row over the deaths of 11 children who allegedly took the contaminated cough syrups, officials said early Sunday. Most of the children were treated at the clinic of Praveen Soni, a paediatrician in Parasia.

Soni, a government doctor who prescribed the syrup to children during their visit to his private clinic, was also suspended.

The Madhya Pradesh government also filed a case against Srisan Pharmaceuticals, a company based in Tamil Nadu’s Kanchipuram district that manufactured the Coldrif cough syrup.

The government had earlier banned the sale of Coldrif, with officials saying that samples of the drug were found to contain 48.6 % diethylene glycol, a highly toxic substance. A sample of the syrup, tested by the government drug analyst at the Drug Testing Laboratory in Chennai, was declared “Not of Standard Quality” by the Tamil Nadu Directorate of Drug Control.

As a precautionary measure, the local administration banned the sale of Coldrif and another cough syrup, ‘Nextro-DS’, on Monday. The test report for Coldrif arrived on Saturday, while that of Nextro-DS is awaited.

According to distraught families, the children first complained of a cold and mild fever in early September. They were then prescribed routine medication, including cough syrups, after which they seemed to recover. But within days, the symptoms returned, followed by a sudden and alarming decrease in urine output. Their condition then worsened into kidney infections, and they later died.

Kidney biopsies then revealed the presence of diethylene glycol contamination.

Chief Minister Mohan Yadav called the deaths “extremely tragic” and said strict action will be taken against those responsible.

“The deaths of children in Chhindwara due to Coldrif syrup are extremely tragic. The sale of this syrup has been banned across Madhya Pradesh. A ban is also being imposed on the sale of other products from the company that manufactures the syrup,” he wrote on X on Saturday.

He said they asked the Tamil Nadu government to test Coldrif as the factory producing the syrup is located in Kanchipuram.

Related Posts

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit